Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002
Christian Herder(Düsseldorf University Hospital), Barbara Thorand(Helmholtz Zentrum München)
Cited by 92
Related Papers
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
|Nature Immunology|2023|738
Associations of plasma proteomics with type 2 diabetes and related traits: results from the longitudinal KORA S4/F4/FF4 Study
|Diabetologia|2023|59
Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
|Nature Immunology|2023|25